U.S. Hospitality Stock News

Regeneron Pharmaceuticals (REGN) is back in focus after the World Health Organization recommended its antibody therapy maftivimab for Ebola trials, along with renewed attention on its wider R&D platform and expanding collaborations. See our latest analysis for Regeneron Pharmaceuticals. Despite the recent WHO spotlight on maftivimab and expanded oncology collaborations, the stock has lost momentum. The 30-day share price return is down 14.97% and the year-to-date share price return is down...

If you are trying to figure out whether AST SpaceMobile's current share price lines up with its underlying value, the recent moves in the stock give you plenty to think about. The share price closed at US$82.41, with the stock falling 12.0% over the last 7 days, rising 10.2% over the last 30 days, declining 1.3% year to date and delivering 114.8% over the last year. The 3 year return is very large at more than 10x and the 5 year return is also very large. Recent coverage has focused on AST...

Earlier this month, Norton, part of Gen Digital, launched the external beta of Norton Family Assistant, a 24/7 AI agent that securely connects to tools like Gmail, calendars, messaging apps, and school platforms to help parents manage family logistics across Windows, macOS, iOS, and Android. The product is built on Gen’s Agent Trust Hub, which emphasizes privacy by keeping each family’s data separate and not using it to train AI models, positioning Gen as an early mover in secure,...

In early June 2026, Navitas Semiconductor announced the launch of its ultra‑high‑voltage UHV‑TO‑247‑4‑ISO SiC package for 1,200–3,300 V applications, alongside a US$500 million at-the-market equity program and the immediate resignation of director Ranbir Singh, former Chair of the Executive Steering Committee. These moves, combined with Navitas’ visibility in NVIDIA’s AI Factory MGX ecosystem for megawatt-scale AI racks, highlight the company’s ambition to fund and scale its GaN and SiC...

Wondering if Tapestry stock still offers value after its recent run, or if expectations have already been priced in? This article breaks down what the current share price could mean for you. The stock last closed at US$147.42, with returns of 5.2% over 7 days, 11.1% over 30 days, 14.2% year to date and 89.2% over 1 year, plus very large 3-year and 5-year gains of 265.6% and 307.6% respectively. Recent attention on Tapestry has been shaped by ongoing coverage of the luxury sector and its role...

In early June 2026, a federal judge allowed a class-action lawsuit over alleged nitrate contamination in Oregon’s Lower Umatilla Basin to proceed against Lamb Weston and several other defendants, while the company also moved to shut its Broekhuizenvorst, Netherlands, production facility as part of a broader supply chain realignment. This combination of escalating environmental litigation risk and footprint consolidation raises fresh questions about Lamb Weston’s long-term costs, community...

Recent commentary on PagSeguro Digital (PAGS) is centering on five years of resilient revenue and operating profit growth in Brazil’s tough macro backdrop, coupled with market claims that the stock appears significantly undervalued. See our latest analysis for PagSeguro Digital. At a share price of US$8.96, PagSeguro Digital has seen a 5.04% 7 day share price return and a 3.82% 30 day share price return, although the 90 day share price return is down 4.38% and the year to date share price...

Copa Holdings (NYSE:CPA) released preliminary traffic statistics for May 2026. Passenger traffic and capacity both showed significant year over year growth. Demand outpaced available seats, leading to a higher load factor versus May 2025. The figures highlight operational expansion and robust travel demand for the carrier. Copa Holdings, the Panama-based airline group listed on the NYSE under ticker CPA, is a key player in Latin American air travel. With the latest May 2026 data indicating...

Earlier this week, Alcoa and the Trois Rivières Port Authority inaugurated Alcoa’s modernized Wharf 17 facilities in Quebec, a US$71.8 million upgrade including two fully electric, closed-loop pneumatic ship unloaders to handle alumina and calcined coke for the Deschambault Smelter. This port investment, backed by broader public funding for the Wharfs 16 and 17 modernization, tightens Alcoa’s control over a key logistics hub while aiming to cut environmental impacts and improve supply-chain...

Recent stock performance and business context CRISPR Therapeutics (CRSP) has drawn attention after a recent pullback, with the stock closing at US$49.80 and showing mixed returns over different time frames that may prompt investors to reassess the story. Over the past day the stock declined 0.9%, over the past week it fell 3.9%, and over the past month it declined 5.6%. Looking back over the past 3 months, the share price is up 2.2%, while the year to date move is a decline of 7.4%. For...

Recent commentary on Watsco (WSO) has focused on the stock trading below some estimates of fair value, with investors weighing solid profitability, a debt free balance sheet, and substantial cash against ongoing industry and partner related risks. See our latest analysis for Watsco. Recent share price moves have been mixed, with the stock down about 9% on a 1 month share price return but up 9.5% year to date and supported by a 5 year total shareholder return of 59.4%. This pattern suggests...

Wondering if Cintas stock is priced fairly or if the market is missing something? This article walks through what the current price might be telling you about value and risk. The stock last closed at US$176.28, with the price falling 2.0% over the past week but rising 7.8% over the past month. The year to date return is down 4.7% and the 1 year return is down 19.8%, compared with gains of 47.4% over 3 years and 108.2% over 5 years. Recent coverage of the commercial services sector has kept...

Why Marex Group (MRX) is back on investor radar Marex Group (NasdaqGS:MRX) has drawn fresh attention after completing an oversubscribed US$500 million perpetual subordinated note issue at a 7.7% coupon, following its Bermuda redomiciliation. This funding move, combined with public backing from institutional investor Night Watch Investment Management, is prompting investors to reassess the stock’s recent performance and valuation. See our latest analysis for Marex Group. At a share price of...

Event context and recent price action Navan (NAVN) has drawn investor attention after a recent pullback, with the stock down 12% over the past day and 6% over the past week, despite gains over the past month and past 3 months. See our latest analysis for Navan. Despite the latest pullback, Navan’s share price return over the past 3 months of 123.93% and year to date share price return of 22.65% suggest momentum has recently been building from a lower base. If this sharp move has you thinking...

MGM Resorts International (MGM) has attracted fresh attention after recent trading, with the stock priced at US$48.97 and showing double digit returns over the past month and past 3 months. Investors are reassessing the company’s mix of gaming and digital operations. See our latest analysis for MGM Resorts International. Beyond the recent jump, MGM’s momentum has been building for some time, with a 34.2% year to date share price return and a 54.33% 1 year total shareholder return pointing to...

Why TransDigm’s recent organic growth focus matters for investors Fresh coverage on TransDigm Group (TDG) is centering on its organic revenue and earnings growth, achieved without acquisitions, and how this ties into profitability, free cash flow, and capital returns for shareholders. See our latest analysis for TransDigm Group. At a share price of US$1,256.05, TransDigm’s stock has gained 4.55% over the past 30 days and 3.41% over 90 days, while the year to date share price return is down...

Earlier this month, Fuse announced a strategic alliance with Fidelity National Information Services to integrate its cloud-native loan origination platform with FIS Asset Finance and FIS AutoSuite, creating an end-to-end origination-to-servicing solution for indirect auto and equipment lenders in the U.S. and Canada. This collaboration aims to modernize lenders’ legacy systems with cloud-based configuration, open APIs, and built-in automation that could streamline underwriting, improve...

Autoliv, Inc. has opened the Autoliv Innovation Center in Vårgårda, Sweden, bringing research, system architecture, testing, prototyping, and pilot production together to accelerate the development of advanced traffic safety solutions. This hub builds on more than 70 years of Swedish safety research and expands Autoliv’s triple-helix collaboration with industry, academia, and society to push next‑generation mobility safety concepts. We’ll now explore how concentrating research, testing, and...

Lennar (LEN) has just reported Q2 2026 results with revenue of US$7.9b, basic EPS of US$1.27, and net income of US$304.8m, while the trailing twelve months show revenue of US$32.7b, basic EPS of US$6.42, and net income of US$1.6b as investors weigh these figures against a reported 4.9% net profit margin over the last year. The company has seen quarterly revenue range from US$6.6b in Q1 2026 to US$9.4b in Q4 2025, with basic EPS moving between US$0.93 and US$2.29 over the past six reported...

Constellation Energy (CEG) has moved back into focus after reporting first quarter 2026 earnings that topped expectations, backed by the Calpine acquisition and new renewable and natural gas projects. See our latest analysis for Constellation Energy. Even with earnings beating expectations and new projects coming online, the share price has been under pressure, with a 30.71% year to date share price decline and a 14.08% drop in 1 year total shareholder return, set against a very large 3 year...

Elevance Health, NYSE:ELV, faces mounting regulatory risk tied to Medicare Advantage risk adjustment data compliance. CMS has set a June 30, 2026 deadline for Elevance Health to remediate compliance issues. Potential sanctions could begin as soon as July 1, 2026 if the company does not meet CMS requirements. For investors tracking Elevance Health at a share price of $404.07, this new regulatory overhang introduces a different type of risk than earnings or valuation debates. The stock is up...

Hamilton Lane stock: what recent returns are telling investors Hamilton Lane (HLNE) has drawn investor attention after a period of weak share performance, with the stock down 7.7% over the past month and 17.3% over the past 3 months. Over the past year, the stock has declined 41.4%, while the year to date move is also a 41.4% decline. This sets a cautious backdrop as investors review the company’s fundamentals and valuation signals. See our latest analysis for Hamilton Lane. At the current...

Wolfspeed (NYSE:WOLF) announced its fifth-generation silicon carbide MOSFET technology for automotive and industrial power electronics. The company also signed an MOU with GE Aerospace to work together on high-voltage silicon carbide power module standards. These updates position Wolfspeed at the center of efforts to define how future high-voltage silicon carbide systems are designed and manufactured. Wolfspeed focuses on silicon carbide materials and power devices that are used in electric...

Harley-Davidson (HOG) has put its "Back to the Bricks" plan at the center of the stock story, with a decision to return Revolution Max and key model production to U.S. plants. See our latest analysis for Harley-Davidson. Recent news around the Back to the Bricks plan and a large share purchase by Pine Valley Investments has arrived alongside a sharp 45.43% 90 day share price return, while the 5 year total shareholder return is down 34.72%. This suggests that momentum has picked up from a...